Published on in Vol 4 , No 3 (2015) :Jul-Sep

Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial

Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial

Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial

Barbora de Courten 1 , MD,MPH,PhD,FRACP ;   Maximilian PJ de Courten 2 , MD,MPH ;   Casper G Schalkwijk 3 , PhD ;   Karen Z Walker 4 , BSc (Hons),MND,GradCert (Higher Ed),PhD ;   Josephine Forbes 5, 6 , PhD

1 Monash Centre for Health Research & Implementation , School of Public Health and Preventive Medicine , Monash University , Melbourne , AU

2 Centre for Chronic Disease , College of Health and Biomedicine , Victoria University , Melbourne , AU

3 Laboratory for Metabolism and Vascular Medicine , Experimental Internal Medicine , Maastricht University, Maastricht , 6211 LK , NL

4 Department of Nutrition and Dietetics , Monash University , Melbourne , AU

5 Mater Research Institute- The University of Queensland , Glycation and Diabetes , TRI , South Brisbane , AU

6 Mater Clinical School , School of Medicine , University of Queensland , St Lucia , AU

Corresponding Author:

  • Barbora de Courten, MD,MPH,PhD,FRACP
  • Monash Centre for Health Research & Implementation
  • School of Public Health and Preventive Medicine
  • Monash University
  • 43-51 Kanooka Grove
  • Clayton
  • Melbourne
  • AU
  • Phone: 61 3 9594 7086
  • Email: barbora.decourten@monash.edu